Certain batched of Macopharma intravenous infusion bags are being recalled due to metal particles being detected in two infusion bags.
Related Article: Nearly twice as many patients in deprived areas prescribed dependency-forming meds
The measures are purely precautionary, and no incidents of this nature have been reported in the UK, Macopharma said yesterday (7 May).
The affected batches were delivered throughout 2017 and 2018, with the last batch delivered in November, Macopharma said.
Related Article: Finding sustainable funding solution is ‘matter of urgency’ for government
As the product has a ‘fast turnover’, it is ‘unlikely’ that there is much remaining stock of the affected batches, Macopharma said.
However, contractors should still check their inventory, quarantine any affected stock and notify Macopharma Customer Services by phoning 01332 206022 or email [email protected].
Related Article: NICE recommends ‘game changer’ wearable tech for type 1 diabetes
The affected batches can be viewed here.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.